The ability of nanofibrils of poly(tetrafluoroethylene) (PTFE) -in situ generated during compounding -to efficiently nucleate crystal growth of the bulk polymers isotactic polypropylene (i-PP), high-density polyethylene (HDPE), polyoxymethylene (POM), polyamide 12 (PA12) and poly(ethylene therephthalate) (PET) is demonstrated. Enhanced nucleation is shown to occur already at PTFE contents as low as 0.001% w/w in i-PP and HDPE. In addition it was found that compounding with PTFE lead to improved clarity of the latter polymers.
The mechanism of reducing light scattering in isotactic polypropylene (i-PP), through the addition of so-called clarifying agents, is studied with small-angle light scattering (SALS) and scanning electron microscopy (SEM). The clarifying agents used in this study depict monotectic phase behavior with i-PP, crystallizing in a relatively narrow concentration range in a nanofibrillar network, providing an ultrahigh nucleation density in the i-PP melt. It is found that the clarifying effect, a dramatically increased transparency and reduced haze, that occurs within the aforementioned additive concentration range, coincides with a change in morphology from strongly scattering spherulites to shish-kebab-like crystalline structures, as evidenced by in situ SALS measurements and confirmed by SEM images. A simple scaling law, relating the diameter of the shish-kebab structures to the fibril diameter and volume fraction of the clarifying agent is proposed, suggesting that the performance of a (fibril-forming) clarifying agent will improve by reducing the fibril diameter and/or increasing the volume concentration of the clarifying agent.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.